Morphic Holding, Inc. (MORF) on Tuesday announced the appointment of Simon Cooper as the Chief Medical Officer.
With a background in immunology and inflammatory diseases, Cooper brings extensive expertise as a clinical development leader. Prior to this role, Cooper held the position of Chief Medical Officer at Keros Therapeutics.
For comments and feedback contact: editorial@rttnews.com
Business News
May 22, 2026 14:46 ET Minutes of the latest Fed policy session was the highlight of the week along with survey data on the U.S. housing market. In Europe, survey data signaled the trends in the euro area private sector. Further, consumer price inflation data from the U.K. was in focus. In Asia, various economic indicators from China drew attention to the health of the economy.